Clinical trial
Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests
NCT00258869 · National Center for Genome Resources, Other · Unknown status
Key facts
| NCT number | NCT00258869 |
|---|---|
| Title | Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests |
| Official title | Plasma Protein Biomarker Based Diagnostics of Outcome in Sepsis & CAP |
| Lead sponsor | National Center for Genome Resources, Other |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH Duke University Henry Ford Hospital Durham VA Medical Center U.S. Fed Pfizer Industry Hoffmann-La Roche |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Sepsis, Septicemia, Sepsis Syndrome, Shock, Septic, Community Acquired Pneumonia |
| Enrollment | 1,200 |
| Start date | Dec 1, 2005 |
| Primary completion | Jul 1, 2010 |
| Completion | Jul 1, 2010 |
| First posted | Nov 28, 2005 |
| Last update posted | Nov 9, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: